RecruitingNot Applicable

The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX and Substance Use (iT-REX)

Thailand140 participantsStarted 2024-02-01

Plain-language summary

This study evaluates a comprehensive transgender-tailored harm reduction service for transgender women, transgender men, and non-binary individuals engaging in chemsex or substance use in Thailand, focusing on PrEP uptake, HIV/STI outcomes, mental health, and socio-legal impacts.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Self-identified transgender women, transgender men, or non-binary persons * Age ≥18 years * HIV-negative * Engaged in chemsex or substance use within past 12 months * Able to provide informed consent Exclusion Criteria: • Inability to communicate in Thai sufficiently to complete study procedures

What they're measuring

PrEP uptake among eligible participants

Timeframe: Baseline to Month 12

PrEP adherence based on self-reported adherence

Timeframe: Months 3, 6, 9, and 12

Trial details

NCT IDNCT07512856

SponsorInstitute of HIV Research and Innovation Foundation, Thailand

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-02-01

Contact for this trial

Nittaya Phanuphak, MD,PhD.

6681 825 3544 nittaya.p@ihri.org

View on ClinicalTrials.gov More HIV Prevention trials